Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Dezember 2015 07:00 ET | Quelle: Vaxart, Inc.

Biota Announces Positive Phase 1 Data for Direct-Acting RSV Antiviral BTA585

ATLANTA, Dec. 18, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address...
11. Dezember 2015 16:01 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals to Participate in the Guggenheim Securities 3rd Annual Boston Healthcare Conference

ATLANTA, Dec. 11, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address...
11. November 2015 16:01 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals to Present at Stifel 2015 Healthcare Conference

ATLANTA, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
06. November 2015 07:00 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals Reports First Quarter Fiscal Year 2016 Financial Results

ATLANTA, Nov. 6, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals to treat...
02. November 2015 07:00 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals Announces Appointment of Mark P. Colonnese as Chief Financial Officer

ATLANTA, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address...
30. Oktober 2015 09:00 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals to Host Conference Call to Report First Quarter Fiscal Year 2016 Financial Results on November 6, 2015

ATLANTA, Oct. 30, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
22. September 2015 16:15 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals to Present at Ladenburg Thalmann 2015 Healthcare Conference

ATLANTA, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
22. September 2015 07:00 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals Appoints Armando Anido and Michael Dunne, M.D. to Its Board of Directors

ATLANTA, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
11. September 2015 07:00 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financial Results

ATLANTA, Sept. 11, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
04. September 2015 12:30 ET | Quelle: Vaxart, Inc.

Biota Pharmaceuticals to Host Conference Call to Report Fourth Quarter and Fiscal Year 2015 Financial Results on September 11, 2015

ATLANTA, Sept. 4, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...

Vorherige Seite